Changeflow GovPing Healthcare & Life Sciences USPTO Patent Application for Disease Treatment ...
Routine Notice Added Final

USPTO Patent Application for Disease Treatment Method

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

The USPTO has published patent application US20260083666A1 for a method of treating diseases and ameliorating pain by administering a composition to the ear canal. The application was filed on April 10, 2025, and published on March 26, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083666A1, detailing a method for treating various diseases and alleviating pain through the administration of a specific composition into the ear canal. The application, filed by inventor Thomas M. Crews, includes extensive CPC classifications related to pharmaceutical compositions and therapeutic uses.

This publication represents a patent application, not a final rule or guidance. It does not impose immediate compliance obligations on any entity. However, companies in the pharmaceutical and biotechnology sectors should be aware of this potential new intellectual property in disease treatment methods. Further analysis would be required if this application leads to an issued patent, which could impact market exclusivity and product development strategies.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHOD OF TREATING DISEASE

Application US20260083666A1 Kind: A1 Mar 26, 2026

Inventors

Thomas M. Crews

Abstract

The present disclosure relates to methods for treating a variety of diseases and/or ameliorating pain by administering to the ear canal of a subject a composition.

CPC Classifications

A61K 9/0046 A61K 9/08 A61K 31/047 A61K 31/137 A61K 31/167 A61K 31/245 A61K 31/4152 A61K 31/439 A61K 31/445 A61K 31/47 A61K 45/06 A61P 1/00 A61P 1/04 A61P 3/04 A61P 11/00 A61P 11/06 A61P 29/00

Filing Date

2025-04-10

Application No.

19175723

View original document →

Named provisions

METHOD OF TREATING DISEASE

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083666A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Labeling Clinical Trial Reporting
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!